Giulio Draetta

Biography

Dr. Giulio Draetta, M.D., Ph.D. serves as Director, Institute for Applied Cancer Science, Professor of Genomic Medicine and Professor of Molecular and Cellular Oncology at The University of Texas MD Anderson Cancer Center. Dr. Draetta is a co-founder of Karyopharm, which develops inhibitors of nuclear transport targets for the treatment of cancer and other diseases. Dr. Draetta served as Chief Research Business Development Officer at Dana Farber Cancer Institute (DFCI). He served as Deputy Director, Belfer Institute for Applied Cancer Science at DFCI. He previously served as Merck Research Laboratories’ Vice President and Worldwide Basic Franchise Head of Oncology. Dr. Draetta served as the Head of Oncology Drug Discovery at Pharmacia and Merck. At Pharmacia and Merck, he focused on the discovery and development of inhibitors of receptor tyrosine kinase signaling, cell division cycle inhibitors, novel cytotoxics, developmental pathway inhibitors, epigenetics and cancer metabolism drugs. While at Cold Spring Harbor Laboratory, at EMBL Heidelberg and the European Institute of Oncology, Dr. Draetta spearheaded fundamental research in the biology of the eukaryotic cell division cycle and of DNA damage induced checkpoints. He was a co-founder and Head of research of Mitotix, Inc. Dr. Draetta served as a Group Leader at Cold Spring Harbor Laboratory, at the European Molecular Biology Laboratory (Heidelberg), and at the European Institute of Oncology (Milan). Dr. Draetta serves as the Chairman of Scientific Advisory Board at Karyopharm Therapeutics, Inc. He has been a Member of Scientific Advisory Board at Enumeral Biomedical Holdings, Inc. since June 2015. He serves as a Member of International Scientific Advisory Board at Istituto Europeo di Oncologia s.r.l. He serves as Member of Scientific Advisory Board of Blueprint Medicines Corp., Epitherapeutics, FORMA Therapeutics, Inc. and Taiho Pharmaceutical Co. He serves as Member of Scientific Advisory Board at Symphogen A/S. Dr. Draetta received his M.D. and Ph.D. degrees from the University of Naples Medical School (Italy), where he also completed post-doctoral training. Dr. Draetta completed additional postgraduate work at the National Cancer Institute and Cold Spring Harbor Laboratory.

Research Interest

Molecular and Cellular Oncology